HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Louis Fehrenbacher Selected Research

taxane

10/2022Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.
1/2018Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.
1/2018Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715).
1/2018Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30.
12/2017Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
9/2013Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial.
7/2013Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
12/2007Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel.
2/2005Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Louis Fehrenbacher Research Topics

Disease

49Breast Neoplasms (Breast Cancer)
10/2022 - 02/2002
27Neoplasms (Cancer)
10/2022 - 06/2005
8Disease Progression
12/2018 - 01/2003
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018 - 06/2004
7Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 01/2003
6Hypertension (High Blood Pressure)
12/2017 - 06/2004
5Amenorrhea
02/2022 - 06/2010
5Fatigue
02/2020 - 07/2013
5Colonic Neoplasms (Colon Cancer)
04/2014 - 06/2007
4Neutropenia
02/2020 - 01/2012
4Peripheral Nervous System Diseases (PNS Diseases)
01/2018 - 07/2013
4Hemorrhage
09/2012 - 05/2005
3Anemia
02/2020 - 01/2018
3Diarrhea
11/2013 - 05/2008
2Nausea
02/2020 - 01/2020
2Alopecia (Baldness)
02/2020 - 12/2012
2Arthralgia (Joint Pain)
01/2019 - 01/2018
2Left Ventricular Dysfunction
01/2019 - 01/2012
2Pain (Aches)
01/2018 - 01/2017
2Cardiotoxicity
12/2017 - 11/2005
2Heart Diseases (Heart Disease)
12/2017 - 02/2002
2Noninfiltrating Intraductal Carcinoma (DCIS)
02/2016 - 02/2016
2Margins of Excision
02/2016 - 02/2016
2Hand-Foot Syndrome
09/2015 - 01/2012
2Exanthema (Rash)
11/2013 - 05/2008
2Heart Failure
11/2013 - 10/2005
2Body Weight (Weight, Body)
01/2012 - 06/2004
2Prostatic Neoplasms (Prostate Cancer)
12/2007 - 02/2007
2Osteoporosis
06/2006 - 03/2006
1Brain Neoplasms (Brain Tumor)
01/2021
1Triple Negative Breast Neoplasms
02/2020
1Vomiting
01/2020
1Urinary Tract Infections (Urinary Tract Infection)
01/2019
1Back Pain (Backache)
01/2019
1Obesity
01/2018
1Chronic Pain
01/2018
1Hyperlipidemias (Hyperlipidemia)
12/2017
1Carcinoid Tumor (Carcinoid)
11/2016
1Neuroendocrine Carcinoma
11/2016
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2016
1Thrombosis (Thrombus)
02/2016

Drug/Important Bio-Agent (IBA)

18Bevacizumab (Avastin)FDA Link
07/2017 - 01/2003
15Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2022 - 06/2005
14Trastuzumab (Herceptin)FDA Link
10/2022 - 02/2002
14Doxorubicin (Adriamycin)FDA LinkGeneric
02/2022 - 06/2005
12Hormones (Hormone)IBA
10/2022 - 04/2008
12TamoxifenFDA LinkGeneric
01/2019 - 06/2005
12Docetaxel (Taxotere)FDA Link
12/2018 - 02/2007
10ErbB Receptors (EGF Receptor)IBA
10/2022 - 11/2005
10AnthracyclinesIBA
10/2022 - 02/2005
10Fluorouracil (Carac)FDA LinkGeneric
02/2022 - 01/2003
9taxaneIBA
10/2022 - 02/2005
9Paclitaxel (Taxol)FDA LinkGeneric
12/2017 - 06/2004
8B 31IBA
01/2019 - 10/2005
8Leucovorin (Folinic Acid)FDA Link
04/2014 - 01/2003
7Capecitabine (Xeloda)FDA Link
01/2021 - 02/2005
7Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2016 - 06/2007
6human ERBB2 proteinIBA
10/2022 - 11/2005
6Monoclonal AntibodiesIBA
10/2007 - 01/2003
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2007 - 01/2003
5GemcitabineFDA Link
02/2020 - 01/2012
4Taxoids (Taxanes)IBA
10/2022 - 06/2010
4Biomarkers (Surrogate Marker)IBA
01/2021 - 09/2014
4atezolizumabIBA
12/2018 - 04/2016
3talazoparibIBA
02/2020 - 01/2018
3Aromatase InhibitorsIBA
01/2019 - 01/2012
3Erlotinib Hydrochloride (CP 358,774)FDA Link
09/2014 - 10/2007
3Estrogen ReceptorsIBA
06/2010 - 06/2005
3Raloxifene Hydrochloride (Evista)FDA Link
06/2010 - 03/2006
3Irinotecan (Camptosar)FDA LinkGeneric
05/2008 - 06/2004
2Epirubicin (Ellence)FDA LinkGeneric
02/2022 - 02/2010
2Clodronic Acid (Clodronate)IBA
01/2021 - 07/2012
2Vinorelbine (Navelbine)FDA LinkGeneric
02/2020 - 01/2018
2Poly Adenosine Diphosphate RiboseIBA
02/2020 - 01/2018
2eribulinFDA Link
02/2020 - 01/2018
2Anastrozole (Arimidex)FDA LinkGeneric
02/2016 - 02/2016
2P-2 (P 2)IBA
06/2010 - 06/2006
2AndrogensIBA
12/2007 - 02/2007
1pertuzumabIBA
10/2022
1Ado-Trastuzumab EmtansineIBA
10/2022
1Zoledronic Acid (Zometa)FDA Link
01/2021
1tucatinibIBA
01/2021
1Anti-Mullerian HormoneIBA
01/2021
1beta-Aminoethyl Isothiourea (AET)IBA
02/2020
1Letrozole (Femara)FDA LinkGeneric
01/2019
1Biological ProductsIBA
11/2018
1LigandsIBA
01/2018
1Duloxetine Hydrochloride (Cymbalta)FDA Link
01/2018
1B7-H1 AntigenIBA
04/2016

Therapy/Procedure

26Drug Therapy (Chemotherapy)
06/2022 - 01/2003
26Therapeutics
02/2022 - 01/2003
10Adjuvant Chemotherapy
10/2020 - 06/2005
5Neoadjuvant Therapy
07/2017 - 02/2010
3Segmental Mastectomy (Lumpectomy)
06/2022 - 02/2016
3Radiotherapy
02/2016 - 01/2011
2Combination Drug Therapy (Combination Chemotherapy)
09/2013 - 06/2004
1Simple Mastectomy
06/2022
1Immunotherapy
12/2018
1Mastectomy (Mammectomy)
01/2018
1Activities of Daily Living (ADL)
01/2017